These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 35256891)

  • 1. The Role of Symptom Duration and Serologic Factors in the Relapse of IgG4-Related Ophthalmic Disease following Surgery: A Retrospective Cohort Study.
    Liu S; Yue Z; Zeng C; Huang X; Li J; Diao J; Chen X; Wei R; Yang W
    Dis Markers; 2022; 2022():5651506. PubMed ID: 35256891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of disease relapse in IgG4-related disease following rituximab.
    Wallace ZS; Mattoo H; Mahajan VS; Kulikova M; Lu L; Deshpande V; Choi HK; Pillai S; Stone JH
    Rheumatology (Oxford); 2016 Jun; 55(6):1000-8. PubMed ID: 26888853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increases in IgE, Eosinophils, and Mast Cells Can be Used in Diagnosis and to Predict Relapse of IgG4-Related Disease.
    Culver EL; Sadler R; Bateman AC; Makuch M; Cargill T; Ferry B; Aalberse R; Barnes E; Rispens T
    Clin Gastroenterol Hepatol; 2017 Sep; 15(9):1444-1452.e6. PubMed ID: 28223204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum IgE in the clinical features and disease outcomes of IgG4-related disease: a large retrospective cohort study.
    Zhou J; Peng Y; Peng L; Wu D; Li J; Jiang N; Li J; Lu H; Liu Z; Luo X; Teng F; Fei Y; Zhang W; Zhao Y; Zeng X
    Arthritis Res Ther; 2020 Oct; 22(1):255. PubMed ID: 33097076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features and relapse risks of IgG4-related ophthalmic disease: a single-center experience in China.
    Zhao Z; Mou D; Wang Z; Zeng Q; Wang Z; Xue J; Ren L; Liu Y; Su Y
    Arthritis Res Ther; 2021 Mar; 23(1):98. PubMed ID: 33789746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revealing the distinct clinical patterns and relapse risk factors in seronegative IgG4-RD patients: A retrospective cohort study over a decade.
    Peng Y; Wang M; Sun R; Nie Y; Zhang N; He X; Sun B; Peng L; Fei Y; Zhou J; Li M; Zhang W
    J Intern Med; 2024 Aug; 296(2):200-212. PubMed ID: 38924246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ophthalmic involvement disparities in clinical characteristics of IgG4-related disease: a retrospective study of 573 patients.
    Gan L; Luo X; Fei Y; Peng L; Zhou J; Li J; Lu H; Liu Z; Zhang P; Liu X; Zhang W
    BMC Ophthalmol; 2021 Dec; 21(1):447. PubMed ID: 34961492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relapse predictors and serologically unstable condition of IgG4-related disease: a large Chinese cohort.
    Liu Y; Zeng Q; Zhu L; Gao J; Wang Z; Wang Z; Yang F; Wang K; Chen D; Xia C; Zhang S; Wang Y; Shen D; Yu G; Li ZG
    Rheumatology (Oxford); 2020 Aug; 59(8):2115-2123. PubMed ID: 32097488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes and pathological characteristics of immunoglobulin G4-related ophthalmic disease versus orbital inflammatory pseudotumor.
    Min HK; Lee YS; Yang SW; Lee J; Kwok SK; Ju JH; Kim WU; Park SH
    Korean J Intern Med; 2019 Jan; 34(1):220-226. PubMed ID: 29050463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and pathological features of patients with antineutrophil cytoplasmic antibody-associated vasculitides concomitant with IgG4-related disease.
    Ma Y; Chen L; Xu Y; Han Q; Yu B; Yuan Y; Zhao J; Yang Y; Chen J; Han F
    Int J Rheum Dis; 2019 Dec; 22(12):2143-2150. PubMed ID: 31631507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics and outcome of IgG4-related disease with hypocomplementemia: a prospective cohort study.
    Peng L; Lu H; Zhou J; Zhang P; Li J; Liu Z; Wu D; Zhang S; Yang Y; Bai W; Wang L; Fei Y; Zhang W; Zhao Y; Zeng X; Zhang F
    Arthritis Res Ther; 2021 Apr; 23(1):102. PubMed ID: 33827676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical manifestations, clinical course, and outcomes of immunoglobulin G4-related disease.
    Phaopraphat K; Ngamjanyaporn P; Narongroeknawin P; Kasitanon N; Katchamart W
    Int J Rheum Dis; 2020 Nov; 23(11):1468-1473. PubMed ID: 32808722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical phenotypes of IgG4-related disease reflect different prognostic outcomes.
    Lanzillotta M; Campochiaro C; Mancuso G; Ramirez GA; Capurso G; Falconi M; Dagna L; Della-Torre E
    Rheumatology (Oxford); 2020 Sep; 59(9):2435-2442. PubMed ID: 32591828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences and similarities between IgG4-related disease with and without dacryoadenitis and sialoadenitis: clinical manifestations and treatment efficacy.
    Wang M; Zhang P; Lin W; Fei Y; Chen H; Li J; Zhang L; Zheng W; Li Y; Zeng X; Zhou J; Lai Y; Liu X; Xue H; Cui Y; Zhou L; Zhao J; Zhang W
    Arthritis Res Ther; 2019 Feb; 21(1):44. PubMed ID: 30709411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes and predictive relapse factors of IgG4-related disease following treatment: a long-term cohort study.
    Peng Y; Li JQ; Zhang PP; Zhang X; Peng LY; Chen H; Zhou JX; Zhang SZ; Yang HX; Liu JJ; Guo HF; Li J; Zhang X; Zhao Y; Zeng XF; Zhang FC; Fei YY; Zhang W
    J Intern Med; 2019 Nov; 286(5):542-552. PubMed ID: 31121062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for extraophthalmic involvement and treatment outcomes in patients with IgG4-related ophthalmic disease.
    Park J; Lee MJ; Kim N; Kim JE; Park SW; Choung HK; Khwarg SI
    Br J Ophthalmol; 2018 Jun; 102(6):736-741. PubMed ID: 28972022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different clinical patterns of IgG4-RD patients with and without eosinophilia.
    Zhang X; Zhang P; Li J; He Y; Fei Y; Peng L; Shi Q; Zhang W; Zhao Y
    Sci Rep; 2019 Nov; 9(1):16483. PubMed ID: 31712579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathological count of IgG4-positive plasmacytes suggests extraophthalmic involvement and relapse in patients with IgG4-related ophthalmic disease: a retrospective study.
    Yuan Y; Meng F; Ren H; Yue H; Xue K; Zhang R
    Arthritis Res Ther; 2022 Apr; 24(1):80. PubMed ID: 35365184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unique patterns of glycosylation in immunoglobulin subclass G4-related disease and primary sclerosing cholangitis.
    Culver EL; van de Bovenkamp FS; Derksen NIL; Koers J; Cargill T; Barnes E; de Neef LA; Koeleman CAM; Aalberse RC; Wuhrer M; Rispens T
    J Gastroenterol Hepatol; 2019 Oct; 34(10):1878-1886. PubMed ID: 30345709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics of a concurrent condition of IgG4-RD and Castleman's disease.
    Zhang X; Zhang P; Peng L; Fei Y; Zhang W; Feng R; Zhang W
    Clin Rheumatol; 2018 Dec; 37(12):3387-3395. PubMed ID: 29948354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.